Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
A medical device company specializing in cardiac electrophysiology and catheter-based treatments.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart mapping catheter put to the test Results expected Sep 2026 (estimated)
- New heart tool aims to simplify AFib treatment Results expected Dec 2026 (estimated)
- New heart tool aims to make AFib treatment faster and safer Results expected Dec 2026 (estimated)
- New catheter combo aims to keep AFib in check longer Results expected Dec 2026 (estimated)
- New heart procedure aims to zap away atrial fibrillation safely Results expected Jul 2027 (estimated)
-
New heart device aims to cut stroke risk in AFib patients
Disease control PausedThis study tests a new device (Laminar) to close the left atrial appendage, a small pouch in the heart, in 1500 people with non-valvular atrial fibrillation. The goal is to see if it is safer and works better than existing devices to reduce the risk of stroke and blood clots. Par…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New heart procedure aims to zap away atrial fibrillation safely
Disease control OngoingThis study is testing a new device that uses pulsed electric fields to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly. The procedure aims to isolate the pulmonary veins to restore normal rhythm. Researchers will enroll 440 people who have not …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New heart device could free AFib patients from blood thinners
Disease control OngoingThis early study tests a device that closes a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to lower the risk of stroke without needing lifelong medication. About 58 participants will be followe…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New catheter combo aims to keep AFib in check longer
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH SF) and software (Ablation Index) work to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. Researchers will track 150 adults who get this procedure to see if they stay free of heart rhythm …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC